- Paper Report
- Published:
Unstable angina pectoris
Critical Care volume 2, Article number: 4432 (2000)
Comments
This excellent review looks at the pathogenesis, medical management and revascularisation procedures involved in this coronary syndrome. The trials involving aspirin, ticlopidine, clopidogrel, platelet glycoprotein IIb/IIIa receptor antagonists and antithrombin therapies in unstable angina are highlighted, and conventional medical therapies discussed (beta-blockers, nitrates and calcium-channel blockers). The changing attitudes regarding revascularisation procedures, with the advent of coronary stenting and glycoprotein IIb/IIIa receptor inhibition, are explored. In addition, investigations are summarised which stratify the risk of further coronary events and influence decisions on whether medical management can be safely continued, or whether angiography and myocardial revascularisation procedures are required. Finally a flow diagram of treatment strategies is presented which stratifies patients into low, intermediate and high risk groups.
References
Yeghiazarians Y, Braustein JB, Askari A, Stone PH: Unstable angina pectoris. New Engl J Med . 1999, 342: 101-114.
Rights and permissions
About this article
Cite this article
Venn, R. Unstable angina pectoris . Crit Care 2, 4432 (2000). https://doi.org/10.1186/ccf-2000-4432
Published:
DOI: https://doi.org/10.1186/ccf-2000-4432